A new study published in Health Affairs found that total spending for six of the seven top causes of death and disease was both cost-effective and beneficial to patient outcomes, the National Pharmaceutical Council (NPC) announced.
The research, produced by NPC and RTI Health Solutions, looked at total spending on key chronic conditions between 1995-2015 to assess the trajectory of cost and “burden of disease.”
“The study clearly demonstrates two truths about health spending,” NPC Vice President of Research Michael Ciarametaro said. “First, investing in medical care can create enormous value for society. … Second, when we think about rising health costs … we need policies that enable a disease-based approach focused on conditions where increasing costs are not justified by associated health gains.”
To read the full article on Health Affairs, click here.
